Free Trial

Agape ATP (ATPC) Competitors

Agape ATP logo
$1.44 +0.04 (+2.86%)
(As of 11/20/2024 ET)

ATPC vs. MRAI, CCM, OPGN, PMD, TOI, BRTX, OTRK, ATIP, MGRX, and KDLY

Should you be buying Agape ATP stock or one of its competitors? The main competitors of Agape ATP include Marpai (MRAI), Concord Medical Services (CCM), OpGen (OPGN), Psychemedics (PMD), Oncology Institute (TOI), BioRestorative Therapies (BRTX), Ontrak (OTRK), ATI Physical Therapy (ATIP), Mangoceuticals (MGRX), and Kindly MD (KDLY). These companies are all part of the "healthcare" industry.

Agape ATP vs.

Marpai (NASDAQ:MRAI) and Agape ATP (NASDAQ:ATPC) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their community ranking, earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends, media sentiment and risk.

In the previous week, Marpai had 2 more articles in the media than Agape ATP. MarketBeat recorded 3 mentions for Marpai and 1 mentions for Agape ATP. Marpai's average media sentiment score of 0.30 beat Agape ATP's score of 0.00 indicating that Marpai is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Marpai
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Agape ATP
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Agape ATP has lower revenue, but higher earnings than Marpai. Agape ATP is trading at a lower price-to-earnings ratio than Marpai, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Marpai$37.15M0.61-$28.75M-$2.64-0.62
Agape ATP$1.43M4.02-$2.10M-$0.73-1.97

Marpai has a net margin of -85.70% compared to Agape ATP's net margin of -194.09%. Marpai's return on equity of 0.00% beat Agape ATP's return on equity.

Company Net Margins Return on Equity Return on Assets
Marpai-85.70% N/A -100.23%
Agape ATP -194.09%-74.71%-56.08%

49.8% of Marpai shares are held by institutional investors. Comparatively, 0.0% of Agape ATP shares are held by institutional investors. 61.3% of Marpai shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Marpai presently has a consensus price target of $6.00, suggesting a potential upside of 265.85%. Given Marpai's stronger consensus rating and higher possible upside, equities research analysts plainly believe Marpai is more favorable than Agape ATP.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Marpai
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Agape ATP
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Marpai received 2 more outperform votes than Agape ATP when rated by MarketBeat users.

CompanyUnderperformOutperform
MarpaiOutperform Votes
2
66.67%
Underperform Votes
1
33.33%
Agape ATPN/AN/A

Summary

Marpai beats Agape ATP on 12 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATPC vs. The Competition

MetricAgape ATPHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$5.75M$652.95M$5.07B$8.90B
Dividend YieldN/A1.94%4.99%4.07%
P/E Ratio-1.9722.3987.8613.46
Price / Sales4.024.441,228.8287.66
Price / CashN/A25.4439.5136.27
Price / Book2.092.796.946.30
Net Income-$2.10M-$10.72M$119.12M$225.93M
7 Day Performance1.41%-1.16%-1.84%-1.32%
1 Month Performance-11.11%-2.51%-3.65%0.60%
1 Year Performance-92.44%387.32%31.64%26.23%

Agape ATP Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATPC
Agape ATP
0.013 of 5 stars
$1.44
+2.9%
N/A-92.4%$5.75M$1.43M-1.9740
MRAI
Marpai
2.0113 of 5 stars
$1.64
+13.1%
$6.00
+265.9%
+80.2%$22.53M$37.15M-0.62150
CCM
Concord Medical Services
0.3453 of 5 stars
$4.35
-3.3%
N/A-58.6%$18.88M$75.69M0.00970Gap Up
OPGN
OpGen
N/A$1.99
+1.5%
N/A-55.8%$16.64M$3.42M0.00100News Coverage
PMD
Psychemedics
0.5329 of 5 stars
$2.33
-0.4%
N/A+11.0%$13.72M$22.10M-4.57140
TOI
Oncology Institute
2.3174 of 5 stars
$0.13
-0.9%
$2.50
+1,808.4%
-94.1%$9.89M$324.24M0.00660Gap Down
High Trading Volume
BRTX
BioRestorative Therapies
3.7191 of 5 stars
$1.41
+0.9%
$18.00
+1,174.9%
-22.2%$9.77M$150,000.00-0.927Analyst Revision
News Coverage
Gap Up
OTRK
Ontrak
2.7304 of 5 stars
$1.81
-1.1%
$45.00
+2,386.2%
-79.4%$7.64M$12.74M0.00250Gap Down
ATIP
ATI Physical Therapy
0.224 of 5 stars
$1.62
+1.9%
N/A-78.2%$7.14M$699.02M0.005,600
MGRX
Mangoceuticals
0.508 of 5 stars
$2.39
-3.2%
N/A-98.1%$5.95M$730,000.000.003Gap Down
KDLY
Kindly MD
0.1582 of 5 stars
$0.97
+6.9%
N/AN/A$5.82MN/A0.00N/AGap Up

Related Companies and Tools


This page (NASDAQ:ATPC) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners